4 minute read
Nov. 28, 2022

BAY-069 (Bayer): a BCAT1/2 inhibitor

BAY-069

oral BCAT1/2 inhibitor favorable PK profile in rats from 788762 cmpd. HTS and SBDD J. Med. Chem. Bayer Pharma AG, Berlin, DE

twitterlinkedinprintemail